| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.058 | 0.2 |